Successful use of recombinant factor VIIa in pelvic fracture haemorrhage.
J Indian Med Assoc
;
2006 Jan; 104(1): 42, 44
Article
in English
| IMSEAR
| ID: sea-97378
ABSTRACT
Recombinant factor VIIa is a novel haemostatic agent and was originally developed to treat haemophilia patients. Successful use of the factor in a 30-year-old male patient with pelvic fracture haemorrhage is being described by the authors.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Pelvic Bones
/
Recombinant Proteins
/
Humans
/
Male
/
Factor VII
/
Factor VIIa
/
Adult
/
Fractures, Bone
/
Hemorrhage
Language:
English
Journal:
J Indian Med Assoc
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS